<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Northwestern_09_01 skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Northwestern/09 01</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><P><TITLE>Notebook</TITLE></P><DIV class="container-fluid" id="cntr"><ARTICLE><H1>Thursday, September 1<SUP>st</SUP></H1><H2>Transformation Results:</H2><P>The gRNA constructs are assembling; Cas9 + YcdO once again failed to assemble.</P><DIV class="row"><DIV class="col-sm-6"><P><STRONG>Figure 1:</STRONG> mRFP in pSB1T3 transformation</P></DIV><DIV class="col-sm-6"><P><STRONG>Figure 2:</STRONG> mRFP in pSB1T3 transformation 2</P></DIV></DIV><DIV class="row"><DIV class="col-sm-6"><P><STRONG>Figure 3:</STRONG> Gibson negative control (no insert)</P></DIV><DIV class="col-sm-6"><P><STRONG>Figure 4:</STRONG> Gibson mix positive control</P></DIV></DIV><DIV class="row"><DIV class="col-sm-6"><P><STRONG>Figure 5:</STRONG> gRNA Gibson retransformation</P></DIV><DIV class="col-sm-6"><P><STRONG>Figure 6:</STRONG> Transformation positive control</P></DIV></DIV><DIV class="row"><DIV class="col-sm-6"><P><STRONG>Figure 7:</STRONG> YcdO + Cas9 Gibson</P></DIV></DIV><H2>Tasks:</H2><DIV class="row"><DIV class="col-sm-2"><P>Jordan</P></DIV><DIV class="col-sm-10"><UL><LI>Imaged periplasm fractions and ClyA-GFP with EVOS
            <DIV class="row"><DIV class="col-xs-6"><P><STRONG>Figure 1:</STRONG> Whole cell ClyA-GFP</P></DIV></DIV></LI></UL></DIV></DIV><DIV class="row"><DIV class="col-sm-2"><P>Michelle</P></DIV><DIV class="col-sm-10"><UL><LI>Transferred TetR-Cas9 induced cultures to 10 mL tubes</LI><LI>Miniprepped GFP 1–3 in storage vectors </LI><UL><LI>GFP1 colony A: 77.7 ng/uL, 260/280: 1.90, 260/230: 2.18</LI><LI>GFP1 colony B: 223.0 ng/uL, 260/280: 1.76, 260/230: 1.25</LI><LI>GFP2 colony A: 65.2 nh/uL, 260/280: 1.92, 260/230: 2.32</LI><LI>GFP2 colony B: 132.1 ng/uL, 260/280: 1.89, 260/230: 2.26</LI><LI>GFP3 colony A: 19.3 ng/uL, 260/280: 1.90, 260/230: 1.50</LI><LI>GFP3 colony B: 19.0 ng/uL, 260/280: 1.76, 260/230: 0.71</LI></UL><LI>Grew 5mL overnight culture (x3) of gRNA from retransformed plate 5 mL LB + 5uL 1000X Tet</LI><UL><LI>Miniprep tomorrow for electroporation cotransformation next week</LI></UL><LI>Grew 5mL overnight culture (x2) of Cas9 from glycerol stock 5 mL LB + 5uL 1000X Cam</LI><UL><LI>Miniprep tomorrow for electroporation cotransformation next week </LI></UL></UL></DIV></DIV><DIV class="row"><DIV class="col-sm-2"><P>Sam</P></DIV><DIV class="col-sm-10"><UL><LI>Prepped questions for Dr. Scheetz</LI><LI>Looked into Australia protocol</LI><LI>Interviewed Dr. Scheetz </LI></UL></DIV></DIV><DIV class="row"><DIV class="col-sm-2"><P>Sara</P></DIV><DIV class="col-sm-10"><UL><LI>Transformed MIT plasmids</LI></UL></DIV></DIV><DIV class="row"><DIV class="col-sm-2"><P>Tasfia</P></DIV><DIV class="col-sm-10"><UL><LI> Made sequencing rxn mixtures for (~500 ng) gRNA-mRFP Gibson product based on Paul’s notes from 7.26.16 using the following primers</LI><UL><LI>VR (Biobrick Rev)</LI><LI>Cas9-Seq4 (Fwd)</LI><LI>VF (Biobrick Fwd)</LI></UL><LI>Gibson Reaction for Ycdo into “Cas9-Lrz-SS 1:3” linearized on 8.29.16</LI><LI>New conditions for Gibson:</LI><UL><LI>Ran 5:1 molar ratio of insert-to-backbone, 15 minutes at 50°C in thermal cycler</LI><LI>“Cas9-YcdO”</LI><UL><LI>1.34 µL backbone</LI><LI>0.14 µL insert (Ycdo)</LI><LI>3.52 µL water</LI><LI>5 µL Gibson mix</LI></UL><LI>Negative Control</LI><UL><LI>1.34 µL backbone</LI><LI>3.66 µL water</LI><LI>5 µL Gibson mix</LI></UL><LI>Positive Control</LI><UL><LI>5µL (+) control</LI><LI>5µL master mix</LI></UL></UL><LI>Transformation</LI><UL><LI>1 µL (+) transformation control (CamR)</LI><LI>2 µL Gibson (+) control (AmpR)</LI><LI>2 µL Gibson (-) Control (CamR)</LI><LI>3 µL Gibson Product (CamR)</LI></UL><LI>Worked on presentation for 9.2.16</LI><LI>Attempted to take inventory of Gibson products (check -20°C inventory spreadsheet)</LI></UL></DIV></DIV></ARTICLE><FOOTER id="nav"><DIV class="row"><DIV class="col-sm-4"><A href="https://2016.igem.org/Team:Northwestern/08_31"> yesterday</A></DIV><DIV class="col-sm-4"><A href="https://2016.igem.org/Team:Northwestern/Notebook">back to calendar </A></DIV><DIV class="col-sm-4"><A href="https://2016.igem.org/Team:Northwestern/09_02">tomorrow </A></DIV></DIV></FOOTER></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>